⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
globenewswire.com
AARD
AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action
prnewswire.com
AARD
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Aardvark Therapeutics, Inc. (AARD) Encourages Shareholders To Inquire About Securities Fraud Class Action
businesswire.com
AARD
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD
globenewswire.com
AARD
Law Offices of Howard G. Smith Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders To Inquire About Securities Fraud Class Action
businesswire.com
AARD
Pomerantz LLP Brings Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Contact Levi & Korsinsky by October 13, 2026 to Join Class Action Against Aardvark Therapeutics, Inc. (AARD)
accessnewswire.com
AARD
October 13, 2026 Deadline Approaching: Join Class Action Against Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky
accessnewswire.com
AARD
Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. (AARD) Shareholders of Class Action Lawsuit and October 13, 2026 Deadline
accessnewswire.com
AARD